To further assess the underlying mechanism behind the altered CLR expression profiles, we analyzed glycan motifs on tumor cells by performing lectin arrays of primary melanoma tumor cells derived from patients using GLYcoPROFILETM technology, and executed correlation between specific glycan motifs and expression of the CLR that we found modulated on tumor-infiltrating DC subsets within corresponding samples. This evidence concerns the gene DCLK3 and neoplasm.